When can I stop taking Valcyte? Detailed explanation in one article

Valcyte (Valcyte), as a drug containing valganciclovir hydrochloride, is widely used to treat and prevent cytomegalovirus (CMV) infection, especially in patients with low immune function, such as after organ transplantation or AIDS patients. So, once a patient starts taking Vancevi, does it mean that he cannot stop taking it? In fact, it all depends on the patient's condition, the stage of treatment and the doctor's professional advice.

First, let’s take a look at the treatment regimen and usage stages of Vancevi. During the treatment period, patients diagnosed with CMV infection, such as CMV retinitis, usually need to take Vancevijo for 21 days until the infection symptoms are effectively controlled. If you stop taking the medicine without authorization during this period, the virus may not be cleared completely and the condition may recur. During the prevention period, in order to prevent CMV infection after organ transplantation, patients may need to take it for 3 to 6 months, or even for 1 year. Stopping the drug at this stage will increase the risk of infection and may affect the function of the transplanted organ in severe cases.

So, why can’t Vancevit be stopped at will? This is because the therapeutic and preventive effects of Vancevir depend on maintaining effective concentrations of the drug in the blood. Once the drug is stopped, the virus may rebound quickly, especially for people with low immunity or severe infection, the risk is greater. For people with low immunity, such as HIV infection or organ transplant patients, the immune system cannot effectively suppress the CMV virus and must rely on drugs for a long time. In patients with severe infections, if the virus is not completely cleared, it may lead to recurrence of the disease or the development of drug resistance.

Of course, there are special circumstances where medication can be discontinued. If the patient's condition is completely relieved, and it is confirmed by examination that the CMV infection has been completely controlled, and the immune function has returned to normal; or the patient has serious adverse reactions, such as anemia, renal damage and other intolerable side effects, the medication needs to be adjusted or discontinued; or the prevention period is over. For patients after transplantation, the medication can be stopped after the prevention period, but regular review is required to monitor the risk of infection.

In short, whether to stop taking Vancevir requires comprehensive consideration of many factors. Patients should strictly follow the doctor’s professional advice and never stop taking the drug without authorization.

xa0

Reference materials

Vansavi Instructions https://www.roche.com